38.2% Pharsight Corporation Convergence 1997 4.9 7.3 - 7.3 148 148 6.0% Point Biomedical Diagnostics & Infrastructure 1997 9.2 0.0 - 0.0 0.00 0.00 NM Prometheus Laboratories, Inc. Therapeutics 1998 7.8 38.8 - 38.8 5.00 5.00 13.4% Salient Interventional Systems Healthcare Devices 1998 27 0.0 - 0.0 0.00 0.00 NM Skila, Inc. Conver